Dopaminergic modulation of rod pathway signals does not affect the scotopic ERG of cat at dark-adapted threshold

1993 ◽  
Vol 70 (4) ◽  
pp. 1681-1691 ◽  
Author(s):  
F. Naarendorp ◽  
P. F. Hitchock ◽  
P. A. Sieving

1. Two rod-driven electroretinogram (ERG) components were recorded to monitor scotopic retinal signals during experimental manipulation of dopamine and gamma-aminobutyric acid (GABA) in normal cat eyes and in eyes pretreated with 6-hydroxydopamine (6-OHDA). The scotopic threshold response (STR) was elicited near absolute threshold to monitor signals traversing the rod pathway near quantal threshold; scotopic PII, which normally begins approximately 2 log units higher, was also monitored. Responses were evaluated by V-log I curves and criterion amplitudes after intravitreal drug injections into intact eyes in vivo. The depletion of dopaminergic cells by pretreating with 6-OHDA was confirmed histologically by immunocytochemical methods. 2. Dopamine abolished the STR and markedly decreased PII in the normal eye. Both 6-OHDA pretreatment and application of the dopamine antagonist, haloperidol, increased the STR amplitudes, but only for stimuli beginning 2 log units above threshold; PII amplitude also was increased. However, neither 6-OHDA pretreatment nor haloperidol affected the STR near absolute threshold. 3. Both GABA and bicuculline suppressed the STR in the normal eye. However, when applied to eyes pretreated with 6-OHDA or concurrent with haloperidol, bicuculline enhanced the STR. GABA enhanced the PII amplitude in the normal eye but had no effect in eyes pretreated with 6-OHDA or in the presence of haloperidol. 4. These results suggest that 1) dopaminergic activity modulates signals in the rod pathway at higher stimulus intensities but not near absolute threshold and 2) GABA can affect the scotopic PII component by acting through dopaminergic cells in the dark-adapted retina.

1965 ◽  
Vol 20 (6) ◽  
pp. 1337-1340 ◽  
Author(s):  
Lenore M. Kopeloff ◽  
Joseph G. Chusid

The antagonistic properties of pyridoxine and gamma aminobutyric acid (GABA) toward convulsant drugs were evaluated by determining their in vivo protective effects when administered parenterally prior to challenge. In a group of 28 monkeys composed of 19 chronic epileptics and 9 controls, pyridoxine and GABA provided variable grades of protection against the convulsant actions of methoxypyridoxine, semicarbazide, and to a lesser degree, pentamethylenetetrazol (Metrazol) and 3,3-methylethylglutarimide (Megimide). Neither pyridoxine nor GABA protected epileptic, brain-operated nonepileptic, or normal monkeys from the convulsant actions of parenteral picrotoxin. No evidence therefore was found in these experiments to support the suggestion that GABA (or pyridoxine) and picrotoxin are antagonistic to each other. experimental epilepsy in Macaca mulatta; gamma aminobutyric acid and vitamin B6 as anticonvulsants Submitted on February 15, 1965


1981 ◽  
Vol 91 (2) ◽  
pp. 205-211 ◽  
Author(s):  
P. G. DOREY ◽  
K. A. MUNDAY ◽  
B. J. PARSONS ◽  
JUDITH A. POAT ◽  
MARY E. UPSHER

A study has been made of the effects of chemical sympathectomy and ganglion blockade on the responses of rat jejunum in vivo to intravenous doses of angiotensin and noradrenaline capable of stimulating fluid transport. Pretreatment with 6-hydroxydopamine (chemical sympathectomy) or pentolinium tartrate (ganglion blockade) abolished the stimulatory actions of angiotensin II but left the responses to noradrenaline unimpaired. Dopamine, like noradrenaline, stimulated fluid transport but this response required very high dopamine infusion rates, was refractory to the dopamine antagonist sulpiride and was inhibited by the α-blocker phentolamine. The possible interaction between angiotensin and the intestinal sympathetics is discussed with reference to control of extracellular fluid volume.


1999 ◽  
Vol 96 (22) ◽  
pp. 12860-12865 ◽  
Author(s):  
K. Baer ◽  
C. Essrich ◽  
J. A. Benson ◽  
D. Benke ◽  
H. Bluethmann ◽  
...  

2008 ◽  
Vol 82 (20) ◽  
pp. 9890-9899 ◽  
Author(s):  
Matthew J. Trifilo ◽  
Manuel Sanchez-Alavez ◽  
Laura Solforosi ◽  
Joie Bernard-Trifilo ◽  
Stefan Kunz ◽  
...  

ABSTRACT After infection with RML murine scrapie agent, transgenic (tg) mice expressing prion protein (PrP) without its glycophosphatidylinositol (GPI) membrane anchor (GPI−/− PrP tg mice) continue to make abundant amounts of the abnormally folded disease-associated PrPres but have a normal life span. In contrast, all age-, sex-, and genetically matched mice with a GPI-anchored PrP become moribund and die due to a chronic progressive neurodegenerative disease by 160 days after RML scrapie agent infection. We report here that infected GPI−/− PrP tg mice, although free from progressive neurodegenerative disease of the cerebellum and extrapyramidal and pyramidal systems, nevertheless suffer defects in learning and memory, long-term potentiation, and neuronal excitability. Such dysfunction increases over time and is associated with an increase in gamma aminobutyric acid (GABA) inhibition but not loss of excitatory glutamate/N-methyl-d-aspartic acid. Enhanced deposition of abnormally folded infectious PrP (PrPsc or PrPres) in the central nervous system (CNS) localizes with GABAA receptors. This occurs with minimal evidence of CNS spongiosis or apoptosis of neurons. The use of monoclonal antibodies reveals an association of PrPres with GABAA receptors. Thus, the clinical defects of learning and memory loss in vivo in GPI−/− PrP tg mice infected with scrapie agent may likely involve the GABAergic pathway.


2015 ◽  
Vol 495 (2) ◽  
pp. 816-826 ◽  
Author(s):  
Gülsel Yurtdaş Kırımlıoğlu ◽  
Yasemin Yazan ◽  
Kevser Erol ◽  
Çiğdem Çengelli Ünel

Sign in / Sign up

Export Citation Format

Share Document